Latest news, press releases, and SEC filings for Arcutis Biotherapeutics Inc (ARQT) https://caymanjournal.com/stock/ARQT en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:32:11 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 I am ready to put my full expertise to work! I understand the strict rules and the need to create a deeply comprehensive, educational summary. However, the document content itself appears to be missing. I received the metadata (Company: Arcutis Biotherapeutics, Inc. and Form: ARS) but the actual PD https://caymanjournal.com/stock/ARQT/sec-filing/0001787306-26-000032 https://caymanjournal.com/stock/ARQT/sec-filing/0001787306-26-000032 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing # 📰 What This Document Is ✉️ This filing is a **Definitive Proxy Statement (DEF 14A)**. In simple terms, this document is a comprehensive "instruction manual" for the company’s annual meeting. It tells stockholders everything they need to know—from who is running the company to how they are paid—an https://caymanjournal.com/stock/ARQT/sec-filing/0001787306-26-000028 https://caymanjournal.com/stock/ARQT/sec-filing/0001787306-26-000028 Tue, 21 Apr 2026 00:00:00 GMT SEC Filing